Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
The Cold & Cough Remedies market in Fiji has been experiencing steady growth in recent years.
Customer preferences: Fijian consumers have shown a growing preference for over-the-counter cold and cough remedies. This can be attributed to several factors, including the convenience and accessibility of these products. Additionally, with the increasing awareness about self-care and the desire to alleviate symptoms quickly, consumers are opting for these remedies to manage their cold and cough symptoms.
Trends in the market: One of the key trends in the Cold & Cough Remedies market in Fiji is the shift towards natural and herbal remedies. Consumers are becoming more conscious about the ingredients used in the products they consume and are seeking alternatives that are perceived as safer and more holistic. This trend is in line with the global market, where natural and herbal remedies have gained popularity.Another trend that is observed in the market is the increasing demand for combination products. These products offer multiple benefits, such as relieving congestion, soothing sore throat, and reducing coughing. The convenience of having multiple remedies in a single product appeals to consumers who are looking for comprehensive solutions to their cold and cough symptoms.
Local special circumstances: Fiji's tropical climate makes it susceptible to seasonal changes and fluctuations in temperature, which can contribute to an increase in cold and cough cases. This creates a constant demand for cold and cough remedies throughout the year. Additionally, the country's tourism industry plays a significant role in the market, as tourists may bring in cold and cough viruses from different regions, leading to a higher demand for remedies.
Underlying macroeconomic factors: The growing middle class in Fiji has contributed to the increased demand for cold and cough remedies. As disposable incomes rise, consumers are more willing to spend on healthcare products to alleviate their symptoms. Furthermore, the government's focus on improving healthcare infrastructure and access to healthcare services has also positively influenced the market.In conclusion, the Cold & Cough Remedies market in Fiji is experiencing growth due to the preferences of consumers for over-the-counter remedies, the trend towards natural and herbal products, and the demand for combination remedies. The local special circumstances, such as the tropical climate and the tourism industry, also contribute to the market's development. Additionally, macroeconomic factors, such as the growing middle class and government initiatives, play a role in driving the market's growth.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights